MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSS, S. B.
Right arrow Articles by AXELROD, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSS, S. B.
Right arrow Articles by AXELROD, J.

Molecular Pharmacology, Vol 8, 50-58, Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics

Electrophoretic Properties of Dopamine beta-Hydroxylase in Several Tissues from Three Species

SVANTE B. ROSS 1, RICHARD WEINSHILBOUM 1, PERRY B. MOLINOFF 1, ELLIOT S. VESELL 1, and JULIUS AXELROD 1

1 Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland 20014, and Department of Pharmacology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033

Dopamine beta-hydroxylase (EC 1.14.2.1) from tissue homogenates of three species was subjected to electrophoresis on polyacrylamide gel and starch blocks. In both systems dopamine beta-hydroxylase in crude homogenates of solid tissues exhibited two electrophoretically distinguishable peaks of activity. The smaller, more slowly migrating peak was eliminated by high-speed centrifugation prior to electrophoresis, suggesting that this peak represented a form of the enzyme bound to the membrane or to a subcellular constituent. This interpretation is supported by partial conversion of dopamine beta-hydroxylase activity from the slowly moving peak to the fast-migrating peak by Triton treatment. Also in harmony with this view are the observations that a nonparticulate tissue such as serum contained only the faster-migrating peak and that prior treatment with reserpine produced elevations of both peaks in solid tissues. The main peak of dopamine beta-hydroxylase activity from human, cow, and rat adrenals differed in electrophoretic mobility, but within each species the major peak of activity from all tissues, including serum, had the same mobility. Human serum dopamine beta-hydroxylase activity migrated with the mobility of a beta-globulin. The major peak of enzyme activity from each species was broad and asymmetrical, and possibly included several distinct molecular forms of the enzyme.

Note:
ACKNOWLEDGMENTS We thank Dr. F. K. Millar, Laboratory of Physiology, National Cancer Institute, for her assistance in the computer analysis of the kinetic data, and Mrs. Dorothy Rutherford and Mrs. Helen Hunt, for their excellent technical assistance.

Submitted on September 1, 1971




This article has been cited by other articles:


Home page
 ScienceHome page
R. M. Weinshilboum, F. A. Raymond, L. R. Elveback, and W. H. Weidman
Serum Dopamine-beta-Hydroxylase Activity: Sibling-Sibling Correlation
Science, September 7, 1973; 181(4103): 943 - 945.
[Abstract] [PDF]

Home page
 ScienceHome page
C. D. Wise and L. Stein
Dopamine.-beta-Hydroxylase Deficits in the Brains of Schizophrenic Patients
Science, July 27, 1973; 181(4097): 344 - 347.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics